MyAverix Finance
SHG · Healthcare
Jiangsu Cowin Biotech Co. Ltd. A (688426)
Biotechnology
Jiangsu Cowin Biotech Co. Ltd. A (688426) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.27B, P/E ratio is 18.00, net margin is -53.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688426
Jiangsu Cowin Biotech Co. Ltd. A (688426) — FAQ
What is Jiangsu Cowin Biotech Co. Ltd. A's market cap?
Jiangsu Cowin Biotech Co. Ltd. A (688426) has a reported market cap of $2.27B (data as of 2026-03-29).
What is 688426's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Cowin Biotech Co. Ltd. A (688426) is 18.00 (data as of 2026-03-29).
Does Jiangsu Cowin Biotech Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Cowin Biotech Co. Ltd. A (688426). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Cowin Biotech Co. Ltd. A in?
Jiangsu Cowin Biotech Co. Ltd. A (688426) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688426 listed on?
688426 is listed on SHG.
What is Jiangsu Cowin Biotech Co. Ltd. A's net margin?
Jiangsu Cowin Biotech Co. Ltd. A (688426) reports a net margin of -53.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.